Patents by Inventor Hugo Lavoie

Hugo Lavoie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240140945
    Abstract: Compounds, compositions and their use in the treatment of a proliferative disease or condition such as a said proliferative disease or disorder is associated with a RAF gene mutation and/or a RAS gene mutation.
    Type: Application
    Filed: November 2, 2023
    Publication date: May 2, 2024
    Inventors: Pierre Louis BEAULIEU, Eric BEAULIEU, Sasmita TRIPATHY, Emeline BENOIT, Joanne TAN, Hugo LAVOIE, Yannick ROSE, Michael DORE, Doris SCHUETZ, Mukund GHAVRE, Jacques BANVILLE
  • Patent number: 11393276
    Abstract: A system is provided for generating a custom hair dye formulation to be dispensed into a single customer container for a particular customer. The system establishes a connection with a user device of the particular customer over a network, receives a selection of a preferred type of expertise of a colorist, determines an available colorist that corresponds to the preferred type of expertise, establishes a video communication session between the particular customer and a colorist device of the determined colorist, causes display of a customer interface to the customer, causes display of a colorist interface to the colorist device, and transmits the generated custom hair dye formulation to a fill site, via the network.
    Type: Grant
    Filed: March 2, 2020
    Date of Patent: July 19, 2022
    Assignee: L'Oreal
    Inventors: Debra Rosenberg, Paul Gambutti, Christopher Hipple, Florent Valceschini, Richard Besen, Guive Balooch, Jennifer Lee, Joseph Kassman, Hugo Lavoie
  • Patent number: 9464313
    Abstract: Disclosed herein are biosensors useful for detecting the dimerization of RAF and/or KSR polypeptides. These biosensors comprise fusion proteins comprising RAF and/or KSR proteins fused to bioluminescent or fluorescent proteins. Also disclosed are methods of using the biosensors to detect and measure the dimerization of RAF/RAF and RAF/KSR polypeptides by resonance energy transfer such as BRET or FRET, for example to screen for inhibitors of dimerization.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: October 11, 2016
    Assignees: MOUNT SINAI HOSPITAL, UNIVERSITÉ DE MONTRÉAL
    Inventors: Hugo Lavoie, Malha Sahmi, Marc Therrien, Thanashan Rajakulendran, Frank Sicheri
  • Publication number: 20140378324
    Abstract: Disclosed herein are mutated RAF and KSR nucleic acids and polypeptides. Also disclosed are methods of using the mutated RAF and KSR to inhibit the dimerization of RAF/RAF and RAF/KSR. Also disclosed are methods of using the mutated RAF and KSR to screen for inhibitors of dimerization.
    Type: Application
    Filed: December 20, 2013
    Publication date: December 25, 2014
    Applicants: MOUNT SINAI HOSPITAL, UNIVERSITE DE MONTREAL
    Inventors: HUGO LAVOIE, Malha Sahmi, Marc Therrien, Thanashan Rajakulendran, Frank Sicheri
  • Publication number: 20120190039
    Abstract: Disclosed herein are mutated RAF and KSR nucleic acids and polypeptides. Also disclosed are methods of using the mutated RAF and KSR to inhibit the dimerization of RAF/RAF and RAF/KSR. Also disclosed are methods of using the mutated RAF and KSR to screen for inhibitors of dimerization.
    Type: Application
    Filed: January 23, 2012
    Publication date: July 26, 2012
    Inventors: Hugo Lavoie, Malha Sahmi, Marc Therrien, Thanashan Rajakulendran, Frank Sicheri